To issue a task order award in the amount of $72,414.00 to provide regulatory support services for clinical trial testing of a monoclonal antibody (MAB) product to prevent and/or treat HIV.
Ended Awarded Last action
- Contract number
- 75N93020F00002
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $47,342
Award facts
- Contract value 58% obligated
-
- $47,341.86 Current, with exercised options
- $81,884.86 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- North Bethesda, MD 20852, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$25,072 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Original award | $72,414 |
About this award
This is a $72,414.00 task order award to The Emmes Company, LLC, a global clinical research organization, to provide regulatory support services for clinical trial testing of a monoclonal antibody (mAb) product to prevent and/or treat HIV. The task order is part of the National Institute of Allergy and Infectious Diseases' (NIAID) Clinical Research Support Services contract, a $545 million Indefinite Delivery Vehicle (IDV) that allows Emmes to provide flexible research support across multiple domains. The task order has a ceiling value of $81,884.86 and a period of performance ending on July 31, 2023. There is no set-aside designation for this award.
Quick answers
Who was awarded contract 75N93020F00002?
75N93020F00002 was awarded to The Emmes Company, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2020.
How much is contract 75N93020F00002 worth?
The government has obligated $47,342 on 75N93020F00002. Its potential value, with all options, is $81,885.
Is contract 75N93020F00002 an order under another contract?
Yes. 75N93020F00002 is a delivery order under HHSN272201700047I, an indefinite delivery contract, on NIAID Clinical Research Support Services 2017-2024.
Was contract 75N93020F00002 competed?
The extent of competition for 75N93020F00002 was full and open competition after exclusion of sources. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award